Increased cardiovascular events in hypertensive patients with insulin resistance: A 13-year follow-up

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 4, 2008, Pages 314-319

  Bigazzi, Roberto ^a   Bianchi, Stefano ^a   Buoncristiani, Enrica ^a   Campese, Vito M ^b  

^a Spedali Riuniti di Livorno   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Diabetes mellitus; Dyslipidemia; Hypertension; Microalbuminuria; Renal disease

Indexed keywords

INSULIN;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; RISK FACTORS;

ANGINA;

EID: 44149121252     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.11.001     Document Type: Article

References (19)

1. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 (1996) 952-957
2. Pyorala M., Miettinen H., Halonen P., Laakso M., and Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20 (2000) 538-544
3. Arnlov J., Lind L., Sundstrom J., Andren B., Vessby B., and Lithell H. Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic function 20 years later. Nutr Metab Cardiovasc Dis 15 (2005) 242-249
4. Hills S.A., Balkau B., Coppack S.W., Dekker J.M., Mari A., Natali A., et al. The EGIR-RISC STUDY (the European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47 3 (2004) 566-570
5. Rewers M., Zaccaro D., D'Agostino R., Haffner S., Saad M.F., Selby J.V., et al. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27 3 (2004) 781-787
6. Hanley A.J., Williams K., Stern M.P., and Haffner S.M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25 (2002) 1177-1184
7. Bianchi S., Bigazzi R., Quiñones Galvan A., Muscelli E., Baldari G., Pecori N., et al. Insulin resistance in microalbuminuric hypertension: sites and mechanisms. Hypertension 26 (1995) 789-795
8. Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
9. Watts G.F., Bennet J.E., Rowe D.J., Morris R.W., Gatling W., Shaw K.M., et al. Assessment of immunochemical methods for determining low concentrations of albumin in urine. Clin Chem 32 (1986) 1544-1548
10. Friedwald W.T., Levy R., and Fredrickson D.S. Estimations of serum low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
11. Allison D.B., Paultre F., Maggio C., Mezzitis N., and Pi-Sunyer F.X. The use of areas under curves in diabetes research. Diabetes Care 18 (1995) 245-250
12. Bianchi S., Bigazzi R., Nenci R., and Campese V.M. Hyperinsulinemia, circadian variation of blood pressure and end organ damage in hypertension. J Nephrol 10 (1997) 325-333
13. Devereux R.B., Waber B., and Roman M.J. Conclusions on the measurement of arterial wall thickness: anatomic, physiologic and methodological considerations. J Hypertens 10 Suppl. 6 (1992) S119-S121
14. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 21 (2002) 2709-2716
15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
16. Reaven G.M. The metabolic syndrome: requiescat in pace. Clin Chem 51 (2005) 931-938
17. Cheal K.L., Abbasi F., Lamendola C., McLaughlin T., Reaven G.M., and Ford E.S. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53 (2004) 1195-1200
18. Tanko L.B., Bagger Y.Z., Qin G., Alexandersen P., Larsen P.J., and Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 111 (2005) 1883-1890
19. The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetic Prevention Program. Diabetes 54 (2005) 2404-2414